Sarepta Therapeutics, Inc.
US ˙ NasdaqGS ˙ US8036071004

SecuritySRPT / Sarepta Therapeutics, Inc.
InstitutionHAP Trading, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
HAP Trading, LLC ownership in SRPT / Sarepta Therapeutics, Inc.

On November 12, 2024 - HAP Trading, LLC filed a 13F-HR form disclosing ownership of 0 shares of Sarepta Therapeutics, Inc. (US:SRPT) valued at $0 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 14, 2024 disclosing 41,077 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

HAP Trading, LLC has a history of taking positions in derivatives of the underlying security (SRPT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 16,000 of underlying shares valued at $524,905 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

SRPT / Sarepta Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-11-12 2024-09-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -41,077 -100.00 0 -100.00
2024-08-14 2024-06-30 13F SAREPTA THERAPEUTICS COM 803607100 41,077 30,054 272.65 6,490 354.80 0.7723
2024-05-13 2024-03-31 13F SAREPTA THERAPEUTICS COM 803607100 11,023 11,023 1,427 0.1634
2021-08-11 2021-06-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -10,182 -100.00 0 -100.00
2021-05-14 2021-03-31 13F SAREPTA THERAPEUTICS COM 803607100 10,182 -441 -4.15 759 -58.09 0.0406
2021-02-16 2020-12-31 13F SAREPTA THERAPEUTICS COM 803607100 10,623 10,623 1,811 0.0522
2019-11-12 2019-09-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -50,466 -100.00 0 -100.00
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS COM 803607100 50,466 50,466 7,668 0.5894
2019-05-10 2019-03-31 13F SAREPTA THERAPEUTICS COM 803607100 0 -15,294 -100.00 0 -100.00
2019-02-12 2018-12-31 13F SAREPTA THERAPEUTICS COM 803607100 15,294 -2,409 -13.61 1,669 -41.62 0.1051
2018-11-09 2018-09-30 13F SAREPTA THERAPEUTICS COM 803607100 17,703 17,703 2,859 0.1804
2017-05-12 2017-03-31 13F SAREPTA THERAPEUTICS COM 803607100 0 -36,556 -100.00 0 -100.00
2017-02-10 2016-12-31 13F SAREPTA THERAPEUTICS COM 803607100 36,556 36,556 -45.13 1,003 -60.42 0.0503
2013-11-12 2013-09-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -66,619 -100.00 0 -100.00
2013-07-31 2013-06-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 66,619 66,619 2,534 0.0857
2013-07-29 2013-06-30 13F SAREPTA THERAPEUTICS COM 803607100 66,619 2,604 0.0824
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-11-12 2024-09-30 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F SAREPTA THERAPEUTICS COM Call 58,000 -45.49 14 -97.90 n/a n/a n/a
2024-05-13 2024-03-31 13F SAREPTA THERAPEUTICS COM Call 106,400 621 n/a n/a n/a
2023-11-09 2023-09-30 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-11 2023-06-30 13F SAREPTA THERAPEUTICS COM Call 24,600 37 n/a n/a n/a
2023-05-12 2023-03-31 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 n/a n/a n/a
2023-02-14 2022-12-31 13F SAREPTA THERAPEUTICS COM Call 11,800 0 n/a n/a n/a
2022-11-14 2022-09-30 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-12 2022-06-30 13F SAREPTA THERAPEUTICS COM Call 12,700 -33.85 36 -43.75 n/a n/a n/a
2022-05-12 2022-03-31 13F SAREPTA THERAPEUTICS COM Call 19,200 -34.69 64 -64.04 n/a n/a n/a
2022-02-14 2021-12-31 13F SAREPTA THERAPEUTICS COM Call 29,400 -11.45 178 -22.61 n/a n/a n/a
2021-11-10 2021-09-30 13F SAREPTA THERAPEUTICS COM Call 33,200 94.15 230 342.31 n/a n/a n/a
2021-08-11 2021-06-30 13F SAREPTA THERAPEUTICS COM Call 17,100 -54.03 52 -37.35 n/a n/a n/a
2021-05-14 2021-03-31 13F SAREPTA THERAPEUTICS COM Call 37,200 5.68 83 -90.19 n/a n/a n/a
2021-02-16 2020-12-31 13F SAREPTA THERAPEUTICS COM Call 35,200 -13.30 846 271.05 n/a n/a n/a
2020-11-13 2020-09-30 13F SAREPTA THERAPEUTICS COM Call 40,600 -16.97 228 -76.13 n/a n/a n/a
2020-08-10 2020-06-30 13F SAREPTA THERAPEUTICS COM Call 48,900 955 n/a n/a n/a
2020-05-08 2020-03-31 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-11 2019-12-31 13F SAREPTA THERAPEUTICS COM Call 140,800 342.77 1,529 2,731.48 n/a n/a n/a
2019-11-12 2019-09-30 13F SAREPTA THERAPEUTICS COM Call 31,800 -77.99 54 -95.80 n/a n/a n/a
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS COM Call 144,500 48.51 1,285 484.09 n/a n/a n/a
2019-05-10 2019-03-31 13F SAREPTA THERAPEUTICS COM Call 97,300 160.16 220 2.33 n/a n/a n/a
2019-02-12 2018-12-31 13F SAREPTA THERAPEUTICS COM Call 37,400 5.65 215 -76.00 n/a n/a n/a
2018-11-09 2018-09-30 13F SAREPTA THERAPEUTICS COM Call 35,400 -25.32 896 -39.25 n/a n/a n/a
2018-08-13 2018-06-30 13F SAREPTA THERAPEUTICS COM Call 47,400 16.46 1,475 432.49 n/a n/a n/a
2018-05-11 2018-03-31 13F SAREPTA THERAPEUTICS COM Call 40,700 2.01 277 42.05 n/a n/a n/a
2018-02-09 2017-12-31 13F SAREPTA THERAPEUTICS COM Call 39,900 59.60 195 83.96 n/a n/a n/a
2017-11-08 2017-09-30 13F SAREPTA THERAPEUTICS COM Call 25,000 106 n/a n/a n/a
2017-05-12 2017-03-31 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-10 2016-12-31 13F SAREPTA THERAPEUTICS COM Call 18,700 -76.06 4 -99.71 n/a n/a n/a
2016-11-09 2016-09-30 13F SAREPTA THERAPEUTICS COM Call 78,100 -79.20 1,371 26.01 n/a n/a n/a
2016-08-05 2016-06-30 13F SAREPTA THERAPEUTICS COM Call 375,400 2,640.15 1,088 4,433.33 n/a n/a n/a
2016-05-12 2016-03-31 13F SAREPTA THERAPEUTICS COM Call 13,700 -80.37 24 -95.34 n/a n/a n/a
2016-02-12 2015-12-31 13F SAREPTA THERAPEUTICS COM Call 69,800 571.15 515 2,929.41 n/a n/a n/a
2015-11-12 2015-09-30 13F SAREPTA THERAPEUTICS COM Call 10,400 17 n/a n/a n/a
2014-11-10 2014-09-30 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-08-11 2014-06-30 13F SAREPTA THERAPEUTICS COM Call 95,500 -6.19 67 -85.68 n/a n/a n/a
2014-02-10 2013-12-31 13F SAREPTA THERAPEUTICS COM Call 101,800 69.95 468 -20.14 n/a n/a n/a
2013-11-12 2013-09-30 13F SAREPTA THERAPEUTICS COM Call 59,900 586 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-13 2025-06-30 13F SAREPTA THERAPEUTICS COM Put 16,000 525 n/a n/a n/a
2023-08-11 2023-06-30 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 n/a n/a n/a
2023-05-12 2023-03-31 13F SAREPTA THERAPEUTICS COM Put 51,900 0 n/a n/a n/a
2022-05-12 2022-03-31 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F SAREPTA THERAPEUTICS COM Put 11,000 -30.82 102 -2.86 n/a n/a n/a
2021-11-10 2021-09-30 13F SAREPTA THERAPEUTICS COM Put 15,900 105 n/a n/a n/a
2021-08-11 2021-06-30 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-14 2021-03-31 13F SAREPTA THERAPEUTICS COM Put 17,200 -19.25 208 7.77 n/a n/a n/a
2021-02-16 2020-12-31 13F SAREPTA THERAPEUTICS COM Put 21,300 85.22 193 54.40 n/a n/a n/a
2020-11-13 2020-09-30 13F SAREPTA THERAPEUTICS COM Put 11,500 -6.50 125 145.10 n/a n/a n/a
2020-08-10 2020-06-30 13F SAREPTA THERAPEUTICS COM Put 12,300 51 n/a n/a n/a
2020-05-08 2020-03-31 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-11 2019-12-31 13F SAREPTA THERAPEUTICS COM Put 22,500 100.89 54 -77.78 n/a n/a n/a
2019-11-12 2019-09-30 13F SAREPTA THERAPEUTICS COM Put 11,200 -94.96 243 164.13 n/a n/a n/a
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS COM Put 222,200 1,521.90 92 -25.20 n/a n/a n/a
2019-05-10 2019-03-31 13F SAREPTA THERAPEUTICS COM Put 13,700 4.58 123 -32.04 n/a n/a n/a
2019-02-12 2018-12-31 13F SAREPTA THERAPEUTICS COM Put 13,100 -25.99 181 144.59 n/a n/a n/a
2018-11-09 2018-09-30 13F SAREPTA THERAPEUTICS COM Put 17,700 -17.29 74 -78.98 n/a n/a n/a
2018-08-13 2018-06-30 13F SAREPTA THERAPEUTICS COM Put 21,400 352 n/a n/a n/a
2017-05-12 2017-03-31 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-10 2016-12-31 13F SAREPTA THERAPEUTICS COM Put 84,100 -58.69 1,170 417.70 n/a n/a n/a
2016-11-09 2016-09-30 13F SAREPTA THERAPEUTICS COM Put 203,600 457.81 226 -58.91 n/a n/a n/a
2016-08-05 2016-06-30 13F SAREPTA THERAPEUTICS COM Put 36,500 550 n/a n/a n/a
2016-05-12 2016-03-31 13F SAREPTA THERAPEUTICS COM Put 0 0 n/a n/a n/a
2016-02-12 2015-12-31 13F SAREPTA THERAPEUTICS COM Put 0 0 n/a n/a n/a
2015-11-12 2015-09-30 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-12 2015-06-30 13F SAREPTA THERAPEUTICS COM Put 510,000 76.59 1,818 116.43 n/a n/a n/a
2013-11-12 2013-09-30 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2013-07-31 2013-06-30 13F/A SAREPTA THERAPEUTICS COM Put 288,800 840 n/a n/a n/a
2013-07-29 2013-06-30 13F SAREPTA THERAPEUTICS COM Put 28,800 840 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.